Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AF-353 (Ro-4), an effective and orally bioavailable antagonist of the P2X3/P2X2/3 receptor, inhibits human and rat P2X3 (pIC50= 8.0).
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 31.00 | |
2 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 70.00 | |
10 mg | In stock | $ 126.00 | |
25 mg | In stock | $ 255.00 | |
50 mg | In stock | $ 356.00 | |
100 mg | In stock | $ 529.00 | |
500 mg | In stock | $ 1,130.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 77.00 |
Description | AF-353 (Ro-4), an effective and orally bioavailable antagonist of the P2X3/P2X2/3 receptor, inhibits human and rat P2X3 (pIC50= 8.0). |
Targets&IC50 | P2X3 (rat):8.0 (pIC50), P2X3 (human):7.3 (pIC50) |
Synonyms | Ro-4 |
Molecular Weight | 400.21 |
Formula | C14H17IN4O2 |
CAS No. | 865305-30-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 32 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AF-353 865305-30-2 Membrane transporter/Ion channel Neuroscience P2X Receptor Ro4 inhibit AF 353 Inhibitor Ro-4 AF353 Ro 4 P2XRs inhibitor